Skip to main content
Premium Trial:

Request an Annual Quote

Fluxion Taps EuroClone as Distributor

NEW YORK (GenomeWeb News) – EuroClone will distribute Fluxion Biosciences' microfluidic platform in a number of European countries under an exclusive agreement, Fluxion said Tuesday.

The agreement covers sales and service for the BioFlux research tools for live cell imaging in the Czech Republic; Slovenia; Croatia; Bosnia Herzegovina; Serbia; Montenegro; Albania; Bulgaria; Romania; Greece; Turkey; Cyprus; Malta; Libya; Morocco; Tunisia; and Algeria.

EuroClone makes and distributes products for use in genomics, proteomics, cell biology, molecular biology, and cytogenetics.

"The relationship will complement EuroClone's product portfolio and give us access to their cell biology customers," Fluxion's director of sales, Mark Atlas, said in a statement.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.